Prospective Clinical Study to Identify Secondary Sentinel Lymph Nodes in Patients With N1/N2b Oral Cavity or H&N Skin Cancers Using Patent Blue V and Indocyanine Green Dyes

NCT07518485 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

N1/N2b Oral Cavity Cancer
Head and Neck Skin Cancer

Interventions

DRUG: Patent blue V dye injection
DRUG: Indocyanine green dye injection

Sponsor

Centre Hospitalier Universitaire Vaudois